Research Supports the Use of Antioxidant Vitamin C to Treat Cancer

Located in Tijuana, Mexico, Oasis of Hope is a medical center for patients with various cancers. The facility’s whole treatment experience means that patients meet with oncologists, nutritionists, and integrative treatment specialists all at a single site. Among its treatments, Oasis of Hope offers high dose intravenous Vitamin C as a cancer therapy.

While drug manufacturers have developed ways for treating cancer, these treatments are expensive, and in some cases, not covered by Medicare. Outside of pharmaceuticals, researchers have looked at alternative cancer treatments as a solution to making treatment affordable, and thus accessible.

High dose intravenous Vitamin C (HDIVC) is one of those solutions. The treatment’s history was doubtful at first because researchers found the studies used to support it were not well-defined and lacked double-blind trials. However, a later re-assessment found that HDIVC was both safe and effective.

Oxidative stress is the core of treating cancer-related conditions using HDIVC. In fact, this therapy has the same effects as chemotherapy and radiation, essentially working to create an imbalance in the production of free radicals (harmful elements that lead to health conditions like cancer) and the body’s ability to detoxify their effects. This imbalance happens naturally when anti-oxidants are absorbed by the body.

Moreover, it is believed that HDIVC has a selective killing affect in that it targets cancer cells in the same way that radiation and chemotherapy do, with a few benefits for the patient. Some immediate effects are that HDIVC has an anti-inflammatory effect, retards cancer growth, reduces side effects of chemotherapy when taken concurrently, and is effective as a stand-alone therapy.